Vickie I. King

  • Citations Per Year
Learn More
BACKGROUND Pruritus is the hallmark clinical sign of atopic dermatitis (AD) in dogs. Preliminary study results suggest that oclacitinib, a selective Janus kinase inhibitor, could reduce pruritus and associated inflammatory skin lesions in dogs with AD. HYPOTHESIS/OBJECTIVES The objective was to evaluate efficacy and safety of oclacitinib (Apoquel®) for(More)
  • 1